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Abstract:  In this study, we investigated the sequential changes in the development of renal tubular cysts in newborn
rats treated with p-cumylphenol (PCP).  Fifteen animals per sex were treated orally with 300 mg/kg/day of PCP for up
to 18 days from postnatal day (PND) 4 and were sacrificed on PNDs 8, 12, 19 and 22 and after a 7 day recovery period.
On PNDs 8 and 12, slight dilatation of the collecting ducts was frequently observed in the medulla and slight papillary
necrosis was also noted in some cases.  These dilated collecting ducts were lined with slightly hyperplastic epithelial
cells.  On PNDs 19 and 22, multiple large cystic changes arising from the collecting ducts in the outer medulla were
seen.  These cystically dilated ducts were also lined with hyperplastic epithelial cells.  During the dosing period, the
labeling index of proliferating cell nuclear antigen in the collecting duct epithelium was higher in the PCP-treated group
than in the control group at all time points.  After a 7 day recovery period, the cystic change still remained, although
the cell density was decreased and the epithelial cells became flattened.  On the other hand, basophilic tubules with
peritubular lymphoid cell infiltration were multifocally observed in the cortex.  In conclusion, PCP induced multiple
renal cysts that developed in the collecting ducts of the outer medulla in neonatal rats, and it is suggested that epithelial
cell proliferation may play some roles in the induction of cystic lesions.  (J Toxicol Pathol 2009; 22: 125–131)
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Introduction
Polycystic kidney is a disease characterized by the
formation of multiple cysts or cystic changes of the renal
uriniferous tubules that has been noted in various animal
species.  Common types of renal polycystic kidney disease
(PKD) in humans include autosomal recessive polycystic
kidney disease (ARPKD), autosomal dominant polycystic
kidney disease (ADPKD)1,2 and medullary cystic disease
complex3.  Similar counterparts are known in other animal
species, such as mice, rats, rabbits, springboks, dogs and
swine4, 5.  Many investigators have reported that PKDs can
be induced by various chemicals, including diphenylamine6,
nordihydroguaiaretic acid7, diphenylthiazole8, alloxan9,
streptozotocin9, ferric-nitrilotriacetate9 and 2-amino-4, 5-
diphenylthiazole10 in young and adult animals and para-
nonylphenol11 and tetrabromobisphenol A12 in newborn
animals.  However, the mechanisms responsible for the
formation of renal cysts by these compounds are not yet
clearly understood, although it has been said that formation
of renal cysts may be associated with cell proliferation,
alteration of tubular basement membrane and Na/K ATPase
localization and/or activity in the target site of the tubules.
On the other hand, it has been suggested that the estrogen
receptors located in the kidneys mediate the cell
proliferation, and Concolino et al. reported that the cell
proliferation may be a potential cause of acquired cystic
kidney disease13.  In addition, ciliary dysfunction may also
play a key role in cyst development, since the cilia contribute
to regulation of intratubular fluid flow14–18.
The chemical p-cumylphenol (PCP), also known as p-
(α, α-dimethylbenzyl) phenol, is widely used as a material
for polycarbonate plastics, surfactants, fungicides and
preservatives.  Hasegawa et al.19 investigated the
susceptibility of newborn rats to 6 industrial chemicals
including PCP by comparing the toxicity in newborns with
that in young animals.  They reported that newborn rats
treated with 100 or 300 mg/kg of PCP by gavage for 18 days
from postnatal day (PND) 4 developed cystic tubular
dilatation in the kidney at the end of the dosing period and
were not completely recovered from the lesion at 9 weeks
after withdrawal of PCP.  They also reported that PCP
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affected the histology of the ovary and uterus, probably due
to its estrogenic activity.
In the present study, we investigated the effects of time-
course histological changes and cell proliferative activity on
the development of renal tubular cyst formation in newborn
rats treated with PCP for up to 18 days from PND 4.
Materials and Methods
Animals and housing conditions
Six pregnant rats of the Sprague-Dawley (Crl:CD)
strain were purchased from Charles River Japan Inc.
(Kanagawa, Japan) on day 18 of gestation and allowed to
deliver spontaneously.  The date of birth was defined as PND
0.  All newborn rats were separated from their dams on PND
3, and those in good health were pooled according to sex and
assigned to the following study.  Five foster mothers were
selected based on health and nursing conditions, and each
mother was allowed to suckle 5 males and 5 females.
All animals were housed in an environmentally
controlled room (23 ± 3°C with a relative humidity of 50 ±
20%, a ventilation rate of 10–15 times per hour and a 12:12
hr light/dark cycle).  All dams and pups of the recovery
group were allowed free access to sterilized basal diet (CRF-
1, Oriental Yeast Co., Ltd., Tokyo, Japan) and tap water.
The experiment was carried out in accordance with the
Guide for Animal Experimentation of Bozo Research Center
Inc.
Chemicals
PCP (CAS no. 599-64-4, Lot no. 101002, purity:
99.88%) was obtained from Sun Techno Chemical Inc.
(Tokyo, Japan).  The test article was dissolved in olive oil.
The solutions were prepared at least once a week and kept
cool and dark until use.
Experimental design
A total of 50 animals consisting 25 male and 25 female
newborn rats were selected on PND 3 and assigned to each
group of the following study by stratified random sampling
based on body weight.  Two animals per sex for each dosing
period group were treated with olive oil and served as the
vehicle control group, and 3 animals per sex for each dosing
period group were treated with 300 mg/kg/day of PCP by
gavage.  The dose level of PCP was selected based on the
results previously reported by Hasegawa et al.19.
Clinical signs and body weights were examined
periodically throughout the experimental period.  Animals
were euthanized by exsanguination under deep ether
anesthesia and sacrificed on PNDs 8, 12, 19 and 22 and after
a 7 day recovery period.  Immediately after macroscopic
observation, the kidneys were weighed, fixed in 10%
buffered formalin, embedded in paraffin wax and sectioned.
Paraffin sections were stained with hematoxylin and eosin
for microscopic examination.  The results of histological
examinations were divided into areas of the cortex, outer
medulla, basal part of the inner medulla and tip of the papilla
(Fig. 1).  Moreover, the sections were also subjected to
immunohistochemistry for proliferating cell nuclear antigen
(PCNA) by the LSAB method (Dako LSAB2 kit; Dako,
Japan) using monoclonal mouse antibody against PCNA
diluted 1:200 (Dako, Japan).  The number of PCNA-positive
nuclei was counted in the same areas as used for histological
examination and expressed as a PCNA-labeling index (%)
without statistical analysis.
Results
Clinical observations and body weights
No deaths or abnormal signs were observed in animals
from both of the control and PCP-treated groups throughout
the experimental period.  In the PCP-treated group, body
weight gain was slightly suppressed during the dosing
period, but it recovered to the control level after the
withdrawal of PCP.
Kidneys weights
In the PCP-treated group, the absolute weight of the
kidneys markedly increased in comparison with that in the
control group on PNDs 19 and 22 and after a 7 day recovery
period (Fig. 2).  The weight was 1.6/1.8 (male/female), 2.0/
1.7 and 1.9/1.4 times heavier on PNDs 19 and 22 and after a
7 day recovery period, respectively.  Similar changes were
detected in the relative weight of the kidneys (kidney weight/
body weight).
Gross findings
Corresponding to the changes in the weight of the
kidneys, enlargement of the kidneys was observed on PNDs
19 and 22 and after a 7 day recovery period.  There were no
abnormal findings in the PCP-treated group examined on
PNDs 8 and 12 as well as in the control group.
Fig. 1. Areas that were observed histologically and
immunohistochemically: cortex, the outer medulla, basal part
of the inner medulla and tip of the papilla.Nakazawa, Kasahara, Ikezaki et al. 127
Histopathological findings 
The histological findings observed in the PCP-treated
group are shown in Table 1 and Figs. 3 and 4.
On PNDs 8 and 12, slightly dilated collecting ducts
lined with slightly hyperplastic epithelium were frequently
observed in the basal part of the inner medulla (Fig. 3a, b, c).
In the tip of the papilla, necrosis and neutrophil infiltration
and reactive hyperplasia of the tubular epithelial cells were
observed in a few animals (Fig. 3d).
On PNDs 19 and 22, dilatation of the collecting ducts in
the basal part of the medulla slightly progressed, and
markedly dilated cystic lesions were produced mainly in the
outer medulla (Fig.3e).  These ducts were lined with
hyperplastic epithelial cells and occasionally contained
desquamated epithelial cells (Fig. 3f).  Such a hyperplastic
change was most prominent in the outer medulla.  In
addition, focal neutrophil infiltration was observed around
the cystically dilated ducts in some animals.  In the tip of the
papilla, slightly dilated papillary ducts were also observed.
After a 7 day recovery period, the cystically dilated
collecting ducts still remained in the outer medulla, although
the cell density was reduced and the epithelial cells became
flattened (Fig. 3g, h).  On the other hand, in the cortex,
multifocal basophilic tubules appeared with peritubular
lymphoid cell infiltration.
In the control group, there were no histopathological
changes throughout the experimental period.
PCNA-labeling index 
In the PCP-treated group, at all time points from PNDs
8 to 22 (except for the basal part of the inner medulla of
females on PND 8) the PCNA-labeling index in the epithelia
Fig. 2. Effects of neonatal exposure to PCP on kidney weights.  Each column represents a mean value from 2 and 3 rats in the control and PCP-
treated groups, respectively.   : 0 mg/kg PCP,  : 300 mg/kg PCP, PND: Postnatal day (PND 29 is a recovery Day 7).
Table 1. Effect of Neonatal Exposure to PCP on Histopathological Findings
Male Female
Administration period Recoverya) Administration period Recovery
N o . o f  r a t s 333333 3 33 3
Findings PNDb) 8 12 19 22 29 8 12 19 22 29
Dilatation, papillary duct – – ±~ + ± ~ + ±~ + – – ± ~ + + ± ~ +
Tip of papilla Necrosis / neutrophil infiltration – ~ ± –––– –  ~  ± – ~ ± –– –
(with / without reactive hyperplasia)
Basal part of Dilatation, collecting duct – ~ ± – ~ ±± † ±† – ~ ±± † – ~ ±† ± ~ +† ± ~ +† – ~ ±
 inner medulla
Dilatation, cystic, collecting duct – – ++‡ ++‡ ++ – – ++‡ ++‡ + ~ ++
Dilatation, collecting duct – – ± ~ +† ± ~ +† – ~ ± – ~ ± – ± ~ +† ± ~ +† – ~ ±
Outer meulla Cell debris, luminal ––± – ~ ±± –––  ~  ± – ~ ± – ~ ±
(cystic dilated collecting ducts)
Neutrophil infiltration ––± – ~ ±± –––  ~  ± – ~ ± – ~ ±
(surrounding cystic dilated collecting duct)
Cortex Basophilia, tubular, multifocal – – – – + – – – – – ~ ±
Cell infiltration, lymphocytic – – – – ± ~ + – – – – ±
a) After a 7 day recovery period. b) Postnatal day. † Lined with slightly hyperplastic epithelial cells.  ‡ Lined with mild (or moderately) hyperplastic
epithelial cells.  Severity grade, –: no remarkable changes, ±: slight, +: mild, ++: moderate.128 Renal Cysts in Newborn Rats Treated with p-Cumylphenol
Fig. 3. Photomicrographs of kidneys with H.E.staining.  (a) Control and (b) PCP-treated neonates on PND 12.  Slightly dilated collecting ducts
are seen in the basal part of the medulla in b.  (c, d) Higher magnification images of b.  Slightly dilated collecting ducts in the basal part of
the medulla, and necrosis in the tip of the papilla.  (e) PCP-treated neonates on PND 19.  Cystic dilatation of the collecting ducts in the
outer medulla.  (f) Higher magnification image of e.  Cyst lined with a hyperplastic epithelium.  (g) PCP-treated neonates after a 7 day
recovery period.  Cystic dilatation of the collecting ducts in the medulla.  (h) Higher magnification image of g.  Cyst lined with a flattened
epithelium. *: cyst lumen.Nakazawa, Kasahara, Ikezaki et al. 129
of the collecting ducts, including the cystically dilated ones,
significantly increased, especially in the outer medulla (Fig.
4a, b, c, d and Fig. 5).  After a 7 day recovery period, the
labeling index was comparable to that in the control group
(Fig. 4e, f and Fig. 5).
Discussion
In the present study, the development of PCP-induced
renal tubular cyst formation was examined in newborn rats
treated with 300 mg/kg/day of PCP from PND 4 up to PND
22.
In the PCP-treated group, body weight gain was slightly
suppressed during the dosing period, however, it recovered
to the normal level following the withdrawal of PCP.  On the
other hand, the kidney weight in the PCP-treated group was
heavier than that in the control group, not only on PNDs 18
and 22, but also after a 7 day recovery period, and these
Fig. 4. Immunohistochemistry for PCNA in the kidneys.  The basal part of the inner medulla of (a) Control and (b) PCP-treated neonates on PND
12.  An increase of PCNA positive cells is seen in b.  The outer medulla of (c) Control and (d) PCP-treated neonates on PND 19.  An
increase of PCNA positive cells is seen in d.  (e) Control and (f) PCP-treated neonates after a 7 day recovery period. The number of PCNA
positive cells is reduced in (f).  *: cyst lumen.130 Renal Cysts in Newborn Rats Treated with p-Cumylphenol
changes in kidney weight were considered to be related to
the histological changes in the kidney noted below.
Slight dilatation of the collecting ducts in the medulla
was observed on PND 8, although no distinct cystic lesions
were present.  After that, some dilated lesions located mainly
in the outer medulla progressed to form multiple large cystic
lesions.  After a 7 day recovery period, the cystic change was
still observed, indicating that PCP-induced cystic lesions are
slow to recover.  On the other hand, multifocal basophilic
tubules appeared in the cortex after PCP withdrawal,
although the basophilic tubules did not appear to be related
to the cystic lesions, since no predictive changes of this
lesion were observed on PNDs 19 and 22.  Papillary damage,
such as neutrophil infiltration and necrosis, was observed on
PNDs 8 and 12, but not after PND 19.  This change may be
related to cyst formation, but the exact relationship between
them is still obscure.
Dilated collecting ducts were generally lined with
hyperplastic epithelial cells until the end of the dosing period
and occasionally accompanied by slight peritubular
inflammatory cell infiltration.  Such hyperplastic change in
the collecting duct epithelia was most prominent in the outer
medulla, and it became more prominent on PNDs 19 and 22
compared with PNDs 8 and 12.  This corresponded well with
the results of the PCNA-labeling index in the collecting duct
epithelia.  Therefore, it is reasonable to consider that there
may be a correlation between proliferation of collecting duct
epithelial cells and dilatation of the collecting ducts.
As mentioned before, PKD has been induced by
diphenylamine6, nordihydroguaiaretic acid7,
diphenylthiazole8, alloxan9, streptozocin9, ferric-
nitrilotriacetate9 and 2-amino-4,5-diphenylthiazole10 in
young and adult animals and para-nonylphenol11 and
tetrabromobisphenol A12 in newborn animals.  The
histological changes induced in newborn rats by para-
nonylphenol are characterized by numerous large cystic
tubules, which develop mainly in the outer medulla and
occasionally contain necrotic epithelial cells and
neutrophils, and by patchy areas of chronic interstitial
nephritis.  Similarly, tetrabromobisphenol A induces
polycystic lesions with tubular epithelial cell hyperplasia in
the cortico-medullary junction.  These findings are roughly
consistent with those of the present study.  Although the
pathogenesis of chemically-induced PKD has not yet been
fully clarified, possible roles of changes of metabolism in
tubular epithelia and/or basement membranes in induction of
PKD have been proposed20.  In addition, renal development
together with immature metabolism is responsible for high
susceptibility to renal injury by extrinsic toxicants in
newborn animals21–24.  Although these factors should be
taken into consideration, the present results suggest that cell
proliferation may play some role in cyst formation, since the
PCNA-labeling indices of the PCP-treated group were
higher than those of the control group even before cyst
formation developed.  However, the PCNA-labeling indices
were increased not only in the outer medulla but also in the
inner medulla, which is not a target area for cyst formation.
A previous study demonstrated that PCP affects the ovaries
and uterus, in which the histological changes include
increased number of atretic follicles and decreased number
Fig. 5. Effects of neonatal exposure to PCP on the PCNA-labeling indices in the kidneys.   : 0 mg/kg PCP,   : 300 mg/kg PCP, PND: Postnatal
day (PND 29 is recovery Day 7).Nakazawa, Kasahara, Ikezaki et al. 131
of corpus luteum in the ovaries and hypertrophy of the
endometrial epithelium in the uterus19.  These histological
findings indicate that PCP may have an estrogenic potential.
In connection with this, Latendresse et al. reported that the
para-nonylphenol-induced polycystic kidney is influenced
by phytoestrogens in the diet11.  Therefore, the potential
estrogenic activity of PCP may also affect renal cyst
formation.
In conclusion, neonatal exposure to PCP induced
multiple cystic lesions arising mainly in the collecting ducts
in the outer medulla.  Although it is suggested that epithelial
cell proliferation may play some role in the formation of
cystic lesions, further studies are needed to clarify the exact
mechanisms of PCP-induced renal cyst formation in
neonatal rats.
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